Rankings
▼
Calendar
XERS FY 2016 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena
XERS
Xeris Biopharma Holdings, Inc.
$982M
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
$1M
99.3% margin
Operating Income
-$13M
-1230.8% margin
Net Income
-$13M
-1228.7% margin
EPS (Diluted)
$-7.17
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$540,000
Balance Sheet
Total Assets
$34M
Total Liabilities
$65M
Stockholders' Equity
-$32M
Cash & Equivalents
$32M
← Q1 2017
All Quarters
